Mikhael, Joseph
Belhadj-Merzoug, Karim
Hulin, Cyrille
Vincent, Laure http://orcid.org/0000-0001-5904-1286
Moreau, Philippe
Gasparetto, Cristina
Pour, Ludek
Spicka, Ivan
Vij, Ravi
Zonder, Jeffrey
Atanackovic, Djordje
Gabrail, Nashat
Martin, Thomas G.
Perrot, Aurore http://orcid.org/0000-0003-0131-8689
Bensfia, Samira
Weng, Qilong
Brillac, Claire http://orcid.org/0000-0002-1743-3211
Semiond, Dorothée
Macé, Sandrine
Corzo, Kathryn P.
Leleu, Xavier http://orcid.org/0000-0002-9822-4170
Article History
Received: 28 October 2020
Revised: 11 March 2021
Accepted: 15 April 2021
First Online: 12 May 2021
Conflict of interest
: J.M.: Honoraria—Amgen, Celgene, GlaxoSmithKline, Janssen, Karyopharm, Sanofi, and Takeda. K.B.M.: Research funding—Celgene; Honoraria—Amgen, Celgene, Janssen, and Takeda; Non-financial support—Abbvie, Celgene, and Takeda. C.H.: Honoraria—Celgene and Sanofi. L.V.: Membership on an entity’s Board of Directors or advisory committees—Janssen, and Takeda; Non-financial support—Celgene, Janssen, Sanofi and Takeda. P.M.: Honoraria—Amgen, Celgene, Janssen-Cilag, Novartis, and Takeda. C.G.: Honoraria—Adaptive, Celgene, Karyopharm, and Takeda; Membership on an entity’s Board of Directors or advisory committees—AbbVie, GlaxoSmithKline, and Karyopharm. L.P.: no relevant financial relationships to disclose. I.S.: Honoraria—Amgen, Bristol-Myers Squibb, Celgene, Janssen-Cilag, Novartis, and Takeda. R.V.: Research funding—Bristol-Myers Squibb, Sanofi, and Takeda; Honoraria—BeiGene, Genentech, Janssen, Karyopharm, Oncopeptides, Sanofi, Securabio, and Takeda. J.Z.: Research funding—Bristol-Myers Squibb and Celgene; Honoraria—Alnylam, Amgen, Caelum, Intellia, Janssen, Oncopeptides, Regeneron, and Takeda. D.A.: no relevant financial relationships to disclose. N.G.: no relevant financial relationships to disclose. T.G.M.: Research funding—Amgen and Sanofi. A.P.: Research funding—Takeda; Honoraria—Amgen, Celgene, Janssen, Sanofi, and Takeda; Non-financial support—Amgen, Celgene, Janssen, Sanofi, and Takeda. S.B., Q.W., C.B., D.S., S.M., and K.P.C.: employed by Sanofi. X.L.: Honoraria—AbbVie, Amgen, Bristol-Myers Squibb, Carsgen Therapeutics Ltd, Celgene, Gilead Sciences, Janssen-Cilag, Karyopharm Therapeutics, Merck, Mundipharma, Novartis, Oncopeptides, Pierre Fabre, Roche, Sanofi, and Takeda; Non-financial support—Takeda.